You are here

  • Home
  • Archive
  • Volume 20, Issue 2
  • Home blood pressure monitoring with patient-initiated drug titration reduces blood pressure in high-risk patients with hypertension

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Home blood pressure monitoring with patient-initiated drug titration reduces blood pressure in high-risk patients with hypertension
  1. Steven M Smith1,2,
  2. Rhonda M Cooper-DeHoff1,3
  1. 1Department of Pharmacotherapy & Translational Research, College of Pharmacy;
  2. 2Department of Community Health & Family Medicine, College of Medicine;
  3. 3Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, PO Box 100486, Gainesville, FL 32610, USA
  1. Correspondence to : Dr Steven M Smith, University of Florida, PO Box 100486, Gainesville, FL 32610, USA; ssmith{at}cop.ufl.edu

http://dx.doi.org/10.1136/ebmed-2014-110109

Statistics from Altmetric.com

    Commentary on: McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomised clinical trial. JAMA 2014;312:799–808.OpenUrlCrossRefPubMedWeb of Science

    Context

    In patients with uncomplicated hypertension, home blood pressure (BP) monitoring combined with medication self-titration has been shown to substantially reduce BP.1 It is unknown whether a similar intervention is effective in high-risk patients with hypertension.

    Methods

    Patients (n=555) aged ≥35 years with a BP ≥130/80 mm Hg, but ≤180/100 mm Hg (treated with 0–3 antihypertensive drugs) and ≥1 high-risk condition were randomly assigned to home BP monitoring with patient-initiated drug titration (intervention arm) or standard care. In the intervention arm, patients and their general practitioner (GP) developed an individualised three-step titration plan at baseline. Patients then measured home BP daily for the first …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions